Navigation Links
DIA Co-located Conference to Examine Outsourcing and Project Management Best Practices
Date:9/30/2008

The Drug Information Association (DIA) will host two co-located conferences from October 23-24 in Washington DC.

Horsham, PA (PRWEB) September 30, 2008 -- The http://www.diahome.org/ [Drug Information Association (DIA)] will host two co-located conferences from October 23-24 in Washington DC.

The http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=17158&eventType=Meeting [3rd Annual Outsourcing Summit] will convene sponsor companies and service providers for a discussion on how to apply outsourcing best practices to one's own projects and corporate culture. Featured topics will include:

  • Proposals, RFPs and Budgets
  • Expediting the Startup Phase
  • The Outsourcing Strategy Revolving Door and its Impact on Performance
  • How to address Persistent Problems
  • Unraveling the mysteries in India, China, and South America outsourcing
  • Sponsor/Provider/Investigator Triad

Learn pharma, biotech, and medical devices project management best practices during http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=17090&eventType=Meeting [Project Management Excellence in Life Sciences: Balancing Art and Science]. This conference will explore the skills, processes, and tools necessary to achieve project management success at one's organization. Topics will include:

  • Strategic planning versus operational excellence
  • Metrics and regulatory impact
  • Strategies for getting a seat at the executive table
  • Tools to efficiently manage projects and programs
  • Redefining project management in a matrix environment
  • Functional PMs versus global PMs
  • Metrics-driven performance
  • Change management

In addition, two pre-Conference tutorials will take place on October 22:

  • Project Management in Life sciences: How Well is it Really Done? Research Outputs from a Global Study
Implementing Critical Chain In The Pharmaceutical And Medical Device Industry

About the http://www.diahome.org/ [Drug Information Association (DIA)]
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

###

Read the full story at http://www.prweb.com/releases/2008/09/prweb1401994.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference
2. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
3. Poniard Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
4. InVitria Touts Product Advantages at Cambridges Cell Culture Conference
5. Advanced Life Sciences to Host Conference Call to Update Investors on Progress of Corporate Initiatives on October 1, 2008
6. Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending PCT Shredder at the Meeting
7. Nano-Bio-Info-Cogno Revolutions to be Explored at Convergence08 Unconference - Forecaster Paul Saffo to Keynote
8. Kendle to Present at the UBS Global Life Sciences Conference
9. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
10. Boston Scientific to Participate in UBS Global Life Sciences Conference
11. Gen-Probe to Webcast Presentation at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Three-Year Initiative Supports Next Generation of ... in Life-Changing Camp Experiences ... affect the lives of children born with rare diseases, as well ... ) is announcing a new initiative designed to positively affect the ... future of rare disease care. --> To mark the ...
(Date:2/8/2016)... BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced ... companies in the TSX Venture 50 TM . ... TSX Venture Exchange, in each of five major industry sectors ... life sciences, diversified industries and technology – based on a ... market cap growth, trading volume and analyst coverage. All data ...
(Date:2/8/2016)... February 8, 2016 ... Limited, an innovation-driven oncology company developing next generation ... toxic, today announced that chairman emeritus of Tata ... in the company as part of the first ... existing investors Navam Capital and Aarin Capital. ...
(Date:2/8/2016)... 2016  BioElectronics Corporation (OTC Pink: BIEL), the ... that it is responding to a notice of ... and Exchange Commission posted on the agency website.  ... the Board of BioElectronics Corporation and the Edward ... The Fuqua School of Business, Duke University.   ...
Breaking Biology Technology:
(Date:1/20/2016)... JOSE, Calif. , Jan. 20, 2016 /PRNewswire/ ... developer of human interface solutions, today announced sampling ... controller solution for wearables and small screen applications ... such as printers. Supporting round and rectangular shapes, ... S1423 offers excellent performance with moisture on screen, ...
(Date:1/13/2016)... January 13, 2016 ... addition of the  "India Biometrics Authentication ... Forecast (2015-2020)"  report to their ... has announced the addition of the  ... - Estimation & Forecast (2015-2020)" ...
(Date:1/8/2016)... , January 8, 2016 ... market and WorldVentures ® , a privately held leading ... an Inc. 5000 fastest-growing company announced that ... investment of $2 million in Nxt-ID to develop a ... on Nxt-ID,s Wocket ® , a unique smart wallet ...
Breaking Biology News(10 mins):